Variable
|
Non-Indigenous
|
Indigenous
|
---|
|
n
|
%
|
n
|
%
|
---|
Participants
|
1494
| |
655
| |
Age, years
| | | | |
15 to 20
|
139
|
9.3%
|
117
|
17.9%
|
21 to 25
|
359
|
24.0%
|
178
|
27.2%
|
26 to 30
|
383
|
25.6%
|
137
|
20.9%
|
31 to 35
|
341
|
22.8%
|
124
|
18.9%
|
36 to 40
|
272
|
18.2%
|
99
|
15.1%
|
Median
|
29
| |
27
| |
Meanc
|
28.9
| |
27.4
| |
Hormonal contraception userc,d
|
643
|
43.3%
|
196
|
30.3%
|
Smokerc,e
|
368
|
24.8%
|
363
|
56.2%
|
Pregnantc,f
|
13
|
0.9%
|
54
|
8.2%
|
Remotenessg
| | | | |
Major cities
|
868
|
58.1%
|
45
|
6.9%
|
Inner regional
|
182
|
12.2%
|
65
|
9.9%
|
Outer regional
|
351
|
23.5%
|
215
|
32.8%
|
Remote
|
78
|
5.2%
|
135
|
20.6%
|
Very remote
|
15
|
1.0%
|
195
|
29.8%
|
Most recent Pap-test resultb
| | | | |
Normal
|
1143
|
81.2%
|
453
|
77.3%
|
Low-grade abnormality
|
116
|
8.2%
|
44
|
7.5%
|
High-grade abnormality
|
5
|
0.4%
|
7
|
1.2%
|
First Pap
|
144
|
10.2%
|
82
|
14.0%
|
Unknown/missing/unsatisfactory
|
19/45/22
| |
21/42/6
| |
Current Pap-test resultb,f
| | | | |
Normal
|
1296
|
88.0%
|
527
|
84.7%
|
Low-grade abnormality
|
156
|
10.6%
|
70
|
11.3%
|
High-grade abnormalityb
|
20
|
1.4%
|
25
|
4.0%
|
Unsatisfactory
|
20
| |
7
| |
-
aWomen's HPV Indigenous Non-Indigenous Urban Rural Study
-
bThree participants with unknown Indigenous status are not included in this table
-
b
P < 0.001 for group Indigenous women versus non-Indigenous women.
-
cData missing for ten non-Indigenous and eight Indigenous participants.
-
dData missing for ten non-Indigenous and nine Indigenous participants.
-
eData missing for eight non-Indigenous and six Indigenous participants.
-
fData missing for two non-Indigenous and twenty-six Indigenous participants.
-
gRemote residence refers to residence in an area categorized as remote or very remote using the Accessibility/Remoteness Index of Australia classification by postcode. Non-remote residence refers to areas categorized as major cities or regional areas.